--- title: "Pre-market hot trades in US stocks: rYojbaba pre-market down 6.39%; Micron Tech pre-market down 3.00%" type: "News" locale: "en" url: "https://longbridge.com/en/news/262437327.md" description: "rYojbaba pre-market down 6.39%; Micron Tech pre-market down 3.00%; Ventyx Biosciences pre-market up 102.07%; Scienture pre-market up 46.98%; HENNESSY CAPITAL INVESTMENT CORP VII COM USD0.0001 CL A(SUBS/RTS) 17/01/2030 pre-market up 42.82%" datetime: "2025-10-23T12:28:12.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/262437327.md) - [en](https://longbridge.com/en/news/262437327.md) - [zh-HK](https://longbridge.com/zh-HK/news/262437327.md) --- # Pre-market hot trades in US stocks: rYojbaba pre-market down 6.39%; Micron Tech pre-market down 3.00% **Pre-market Hot Trades in US Stocks** rYojbaba is down 6.39% in pre-market trading. Based on recent news, 1. On October 21, Ryojbaba Co. Ltd. released an announcement on the EDGAR system, disclosing the company's latest financial status and future outlook. The announcement showed that the company's third-quarter performance fell short of expectations, with both revenue and net profit declining, leading to a loss of investor confidence and a significant drop in stock price. 2. On October 20, market rumors suggested that Ryojbaba Co. Ltd. might face a regulatory investigation regarding compliance issues in certain business areas. Although the company has not officially responded, this news has raised widespread concerns in the market, further depressing the stock price. 3. On October 19, analysts downgraded their rating on Ryojbaba Co. Ltd., citing growth pressures in a highly competitive market environment. Analysts expect the company's profitability to continue facing challenges in the coming quarters, and this negative outlook has led to a sustained decline in stock price. The market remains cautious about the overall performance of tech stocks. Micron Tech is down 3.00% in pre-market trading. Based on recent news, 1. On October 23, Micron Tech announced the launch of the 192GB SOCAMM2 small compression additional memory module, focusing on the low-power memory needs of AI data centers. This move demonstrates Micron's ability to respond to the increasingly complex demands of AI platforms and strengthens its partnership with NVIDIA, promoting the market application of low-power server memory. 2. On October 22, Micron Tech's CEO stated that the company would invest $200 billion in memory manufacturing in the United States. This news has attracted market attention, showing the company's proactive layout in expanding production capacity and addressing future demand. 3. On October 20, Mizuho and Barclays raised Micron Tech's target price to $240, maintaining an "Outperform" rating. Analysts' optimistic expectations further boosted market confidence in Micron Tech's future performance. Semiconductor demand remains strong, and market volatility has intensified. **Top Gainers in Pre-market Trading of US Stocks** Ventyx Biosciences is up 102.07% in pre-market trading. Based on recent news, 1. On October 23, Ventyx Biosciences announced that its oral drug VTX3232 significantly reduced key inflammatory markers associated with heart disease in patients with obesity and cardiovascular risk. The drug reduced hsCRP levels by approximately 80% in the first week, and IL-6 levels fell below the cardiovascular risk threshold. This news drove a substantial increase in stock price. 2. On October 23, Ventyx Biosciences released the results of the phase II trial for VTX3232, showing that the drug significantly reduced hsCRP levels in monotherapy and further decreased inflammatory markers when used in combination with Novo Nordisk's semaglutide. This result caused the stock price to soar by 86.53% in after-hours trading 3. On October 23, Ventyx Biosciences' stock rose 76.26% over the past 12 months, with news on that day triggering a large volume of trading, reaching 35 million shares, compared to an average daily trading volume of about 1.3 million shares over the past three months. The biotechnology sector has shown strong performance recently, with significant capital inflows. Scienture, pre-market up 46.98%, has had no significant news recently. Trading is active, with clear capital flows; considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. HENNESSY CAPITAL INVESTMENT CORP VII COM USD0.0001 CL A(SUBS/RTS) 17/01/2030, pre-market up 42.82%, has had no significant news recently. Trading is active, with clear capital flows; considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation ### Related Stocks - [RYOJ.US](https://longbridge.com/en/quote/RYOJ.US.md) - [MU.US](https://longbridge.com/en/quote/MU.US.md) ## Related News & Research - [Micron's stock gets a boost. Are Samsung's problems helping?](https://longbridge.com/en/news/287092903.md) - [Why Micron Stock Just Popped Again](https://longbridge.com/en/news/286958150.md) - [Micron's (MU) Rally Looks Big. The AI Memory Story Still Looks Bigger](https://longbridge.com/en/news/287060636.md) - [Covestor Ltd Sells 3,355 Shares of Micron Technology, Inc. $MU](https://longbridge.com/en/news/287029115.md) - [Micron and Texas Instruments Get Price Target Boost as Top Mizuho Analyst Sees Strong Chip Demand](https://longbridge.com/en/news/286954735.md)